Tirzepatide Shortage Timeline and History
GLP-1 medication shortages continue to frustrate users across the US. This page provides up-to-date tracking on what’s available and what to do.
Current Availability
Currently, the shortage situation for GLP-1 medications differs dramatically by:
- Product and dosage: Lower starter doses are often more available than higher strengths
- State and region: Supply chains prioritize high-volume markets while rural areas face more difficulty
- Pharmacy type: Mail-order options may stock what chain pharmacies can’t get
By Strength
Initial Titration Strengths
Low-dose strengths are usually more available because:
- Less demand remains on initial dosing long-term
- Pharma companies focus production on starter doses to guarantee onboarding capability
Higher Dosing
Higher doses face more pressure because:
- The majority of users end up on higher doses and remain
- Output can’t keep up with growing demand
If You’re Affected
First Actions
- Phone before visiting — never drive to any location without confirming that they have it
- Try multiple locations — try several locations across different chains
- Request to be called — some locations can alert you when your dose comes in
Extended Supply Issues
- Contact your doctor about dose adjustments — a doctor can prescribe a different strength
- Ask about 503B pharmacy products — should your prescription be on the FDA shortage list, custom formulations can be prescribed
- Contact the drug maker — both Novo Nordisk and Eli Lilly have programs to help patients find supply
Where to Track
Monitor these channels to stay informed:
- FDA Drug Shortage Database — the authoritative source
- Novo Nordisk and Eli Lilly — supply updates straight from the source
- Retail pharmacy apps — can indicate medication status
- Support groups — community members share real-time stock findings
New data is added regularly.